Sorafenib (S) in patients (pts) with advanced hepatocellular carcinoma (HCC): Safety and efficacy in Child-Pugh (CP) class A and B patients.
Tiziana Pressiani
No relevant relationships to disclose
Corrado Boni
No relevant relationships to disclose
Lorenza Rimassa
No relevant relationships to disclose
Roberto Labianca
No relevant relationships to disclose
Stefano Fagiuoli
No relevant relationships to disclose
Andrea Ardizzoni
No relevant relationships to disclose
Paolo Foa
No relevant relationships to disclose
Enrico Cortesi
No relevant relationships to disclose
Laura Giordano
No relevant relationships to disclose
Armando Santoro
No relevant relationships to disclose